The other has to do with reducing inflammation
It preserves lean muscle mass, improves cardiovascular fitness, supports mental health, strengthens bones, and helps maintain weight loss long-term after treatment ends
Tirzepatide, the first dual GIP/GLP-1 receptor co-agonist approved for type 2 diabetes in the USA, Europe, and the UAE, targets both appetite and glucose control
Sleep quality, stress levels, and baseline metabolic rate all modulate how quickly your brain registers the medication's appetite-suppressing effects
GLP-1 receptor agonists, such as Semaglutide and Tirzepatide, are designed to mimic a hormone your body naturally produces
But before you decide to split your dose, you need to understand what the data actually says about efficacy, as well as the significant safety risks that come with hacking these pens